The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Epizyme, Inc. Common Stock 29428V104 33,430 3,838,166 SH   SOLE   3,838,166 0 0
Progyny, Inc. Common Stock 74340E103 369,250 8,295,896 SH   SOLE   8,295,896 0 0
Pulmonx Corporation Common Stock 745848101 45,510 994,971 SH   SOLE   994,971 0 0
TransMedics Group, Inc. Common Stock 89377M109 38,304 923,221 SH   SOLE   923,221 0 0